Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Wacker Biotech GmbH, a prominent player in the biopharmaceutical industry, is headquartered in Germany (DE) and operates extensively across Europe and North America. Founded in 2000, the company has established itself as a leader in contract development and manufacturing, specialising in the production of complex biopharmaceuticals, including proteins and vaccines.
Wacker Biotech is renowned for its state-of-the-art facilities and innovative technologies, which enable the efficient production of high-quality biologics. The company’s commitment to excellence is reflected in its adherence to stringent regulatory standards and its successful collaborations with various global partners. With a strong market position, Wacker Biotech continues to achieve significant milestones, solidifying its reputation as a trusted provider in the biopharmaceutical sector.
+58 vs industry average
Wacker Biotech GmbH’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Wacker Biotech GmbH yet.
Wacker Biotech GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Wacker Chemie AG, which influences its climate commitments and initiatives.
Wacker Chemie AG, at the first cascade level, has established various climate initiatives, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Wacker Biotech GmbH have not been disclosed.
As a subsidiary, Wacker Biotech GmbH aligns with the broader sustainability goals set by Wacker Chemie AG, which may include commitments to reduce emissions across Scope 1, 2, and 3 categories. The absence of direct emissions data suggests that Wacker Biotech GmbH is still in the process of developing its specific climate strategy and targets.
Overall, while Wacker Biotech GmbH inherits a commitment to sustainability from its parent company, detailed emissions metrics and reduction targets remain unspecified at this time.
No climate goals have been disclosed for Wacker Biotech GmbH yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more